The diverse actions of nicotine and different extracted fractions from tobacco smoke against hapten-induced colitis in rats

Toxicological Sciences

Volumn 87, Issue 1, 2005, Pages 285-295

  Ko, Joshua K S ^a   Cho, Chi Hin ^b  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chemotactic factors; Colitis; Neutrophils; Nicotine; Tobacco smoke

Indexed keywords

CHEMOKINE; CHLOROFORM; CYTOKINE; FREE RADICAL; HAPTEN; INTERLEUKIN 1BETA; LEUKOTRIENE B4; LUMINOL; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; NICOTINE; TOBACCO SMOKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG ACTIVITY; DRUG MECHANISM; ENZYME ACTIVITY; EXPOSURE; MALE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RAT; RAT STRAIN; TOBACCO;

ANIMALS; CHEMOKINE CCL2; COLITIS; COLON; DINITROFLUOROBENZENE; FREE RADICALS; INTERLEUKIN-1; MALE; NEUTROPHIL ACTIVATION; NEUTROPHIL INFILTRATION; NICOTINE; RATS; RATS, SPRAGUE-DAWLEY; SMOKE; TOBACCO;

ANIMALIA; NICOTIANA TABACUM;

EID: 24044530418     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfi238     Document Type: Article

References (57)

1. Aoshiba, K., Nagai, A., and Konno, K. (1994). Nicotine prevents a reduction in neutrophil filterability induced by cigarette smoke exposure. Am. J. Respir. Crit. Care Med. 150, 1101-1107.
2. Banks, C., Bateman, A., Payne, R., Johnson, P., and Sheron, N. (2003). Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J. Pathol. 199, 28-35.
3. Bless, N. M., Huber-Lang, M., Guo, R. F.,Warner, R. L., Schmal, H., Czermak, B. J., Shanley, T. P., Crouch, L. D., Lentsch, A. B., Sarma, V., et al. (2000). Role of CC chemokines (macrophage inflammatory protein-1beta, monocyte chemoattractant protein-1, RANTES) in acute lung injury in rats. J. Immunol. 164, 2650-2659.
4. Bravo, L. (1998). Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev. 56, 317-333.
5. Chen, C., and Loo, G. (1995). Cigarette smoke extract inhibits oxidative modification of low density lipoprotein. Atherosclerosis 112, 177-185.
6. Chow, J. Y. C., and Cho, C. H. (1996). An experimental model for studying passive cigarette smoking effects on gastric ulceration. Life Sci. 58, 2415-2422.
7. Chow, J. Y. C., Ma, L., Zhu, M., and Cho, C. H. (1997). The potentiating actions of cigarette smoking on ethanol-induced gastric mucosal damage in rats. Gastroenterology 113, 1188-1197.
8. Claman, H. N. (1984). Anti-inflammatory effects of corticosteroids. Clin. Immunol. Allergy 4, 317-319.
9. 4. Int. J. Biochem. Cell Biol. 30, 173-183.
10. Di Loreto, S., Caracciolo, V., Colafarina, S., Sebastiani, P., Gasbarri, A., and Amicarelli, F. (2004). Methylglyoxal induces oxidative stress-dependent cell injury and up-regulation of interleukin-1beta and nerve growth factor in cultured hippocampal neuronal cells. Brain Res. 1006, 157-167.
11. Elson, C. O., Sartor, R. B., Tennyson, G. S., and Riddell, R. H. (1995). Experimental models of inflammatory bowel disease. Gastroenterology 109, 1344-1367.
12. Galvez, J., Coelho, G., Crespo, M. E., Cruz, T., Rodriguez-Cabezas, M. E., Concha, A., Gonzalez, M., and Zarzuelo, A. (2001). Intestinal anti-inflammatory activity of morin on chronic experimental colitis in the rat. Aliment. Pharmacol. Ther. 15, 2027-2039.
13. Green, J.T., Evans, B.K., Rhodes, J., Thomas, G.A., Ranshaw, C., Feyerabend, C., and Russell, M. A. (1999). An oral formulation of nicotine for release and absorption in the colon: Its development and pharmacokinetics. Br. J. Clin. Pharmacol. 48, 485-493.
14. Guo, X., Wang, W. P., Ko, J. K. S., and Cho, C. H. (1999). Involvement of neutrophils and free radicals in the potentiating effects of passive cigarette smoking on inflammatory bowel disease in rats. Gastroenterology 117, 884-892.
15. Guslandi, M. (1999). Long-term effects of a single course of nicotine treatment in acute ulcerative colitis: Remission maintenance in a 12-month follow-up study. Int. J. Colorectal Dis. 14, 261-262.
16. Guslandi, M., and Tittobello, A. (1998). Outcome of ulcerative colitis after treatment with transdermal nicotine. Eur. J. Gastroenterol. Hepatol. 10, 513-515.
17. Harries, A. D., Baird, A., and Rhodes, J. (1982). Non-smoking: A feature of ulcerative colitis. Br. Med. J. Clin. Res. ed. 284, 706.
18. Hawkins, J. V., Emmel, E. L., Feuer, J. J., Nedelman, M. A., Harvey, C. J., Klein, H. J., Rozmiarek, H., Kennedy, A. R., Lichtenstein, G. R., and Billings, P. C. (1997). Protease activity in a hapten-induced model of ulcerative colitis in rats. Dig. Dis. Sci. 42, 1969-1980.
19. He, W., Pelletier, J. P., Martel-Pelletier, J., Laufer, S., and Di Battista, J. A. (2002). Synthesis of interleukin 1beta, tumor necrosis factor-alpha, and interstitial collagenase (MMP-1) is eicosanoid dependent in human osteoarthritis synovial membrane explants: Interactions with anti-inflammatory cytokines. J. Rheumatol. 29, 546-553.
20. Ingram, J. R., Routledge, P., Rhodes, J., Marshall, R.W., Buss, D. C., Evans, B. K., Feyerabend, C., and Thomas, G. A. (2004). Nicotine enemas for treatment of ulcerative colitis: A study of the pharmacokinetics and adverse events associated with three doses of nicotine. Aliment. Pharmacol. Ther. 20, 859-865.
21. Kamisaki, Y., Wada, K., Nakamoto, K., Kishimoto, Y., Ashida, K., and Itoh, T. (1997). Inhibition by cigarette smoke of lipid peroxidation-induced neurotransmitter release. Life Sci. 60, PL229-PL233.
22. Kennedy, L. D. (1996). Nicotine therapy for ulcerative colitis. Ann. Pharmacother. 30, 1022-1023.
23. Kmiec, Z. (1998). Cytokines in inflammatory bowel disease. Arch. Immunol. Ther. Exp. (Warsz) 46, 143-155.
24. Ko, J. K. S., Sham, N. F., Guo, X., and Cho, C. H. (2001). Beneficial intervention of experimental colitis by passive cigarette smoking through the modulation of cytokines in rats. J. Invest. Med. 49, 21-29.
25. Koutroubakis, I., Manousos, O. N., Menuwissen, S. G., and Pena, A. S. (1996). Environmental risk factors in inflammatory bowel disease. Hepatogastroenterology 43, 381-393.
26. Kuwabara, K.,Yasui, K., Jyoyama, H., Maruyama, T., Fleisch, J. H., and Hori, Y. (2000). Effects of the second-generation leukotriene B(4) receptor antagonist, LY293111Na, on leukocyte infiltration and collagen-induced arthritis in mice. Eur. J. Pharmacol. 402, 275-285.
27. Lapenna, D., DeGioia, S., Mezzetti, A., Ciofani, G., Consoli, A., Marzio, L., and Cuccurullo, F. (1995). Cigarette smoke, ferritin, and lipid peroxidation. Am. J. Respir. Crit. Care Med. 151, 431-435.
28. Lauritsen, K., Laursen, L. S., Bukhave, K., and Rask-Madsen, J. (1989). Inflammatory intermediates in inflammatory bowel disease. Int. J. Colorectal Dis. 4, 75-90.
29. Liu, E. S. L., Ye, Y., Shin, V. Y., Yuen, S., Leung, S., Wong, B. C. Y., and Cho, C. H. (2003). Cigarette smoke exposure increases ulcerative colitis-associated colonic adenoma formation in mice. Carcinogenesis 24, 1407-1413.
30. 4. Dig. Dis. Sci. 32, 1380-1388.
31. Ma, L., Wang,W. P., Chow, J. Y. C., Lam, S. K., and Cho, C. H. (2000). The role of polyamines in gastric mucus synthesis inhibited by cigarette smoke or its extract. Gut 47, 170-177.
32. MacDermott, R. P. (1999). Chemokines in the inflammatory bowel diseases. J. Clin. Immunol. 19, 266-272.
33. Mahida, Y. R., Wu, K. C., and Jewell, D. P. (1989). Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease. Gut 30, 1362-1370.
34. 4. J. Immunol. 163, 6148-6154.
35. Mazzucchelli, L., Hauser, C., Zgraggen, K., Wagner, H. E., Hess, M. W., Laissue, J. A., and Mueller, C. (1996). Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease. J. Pathol. 178, 201-206.
36. McCormack, G., Moriarty, D., O'Donoghue, D. P., McCormack, P. A., Sheahan, K., and Baird, A. W. (2001). Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflam. Res. 50, 491-495.
37. Montero, A., Nassar, G. M., Uda, S., Munger, K. A., and Badr, K. F. (2000). Reciprocal regulation of LTA(4) hydrolase expression in human monocytes by gamma-interferon and interleukin 4 and 13: Potential relevance to leukotriene regulation in glomerular disease. Exp. Nephrol. 8, 258-265.
38. 4 formation. Nippon Yakurigaku Zasshi 104, 447-457 (Abstract).
39. Nielsen, O. H., and Rask-Madsen, J. (1996). Mediators of inflammation in chronic inflammatory bowel disease. Scand. J. Gastroenterol. 216(Suppl.), 149-159.
40. Pryor, W. A., and Stone, K. (1993). Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann. N. Y. Acad. Sci. 686, 12-27.
41. Reimund, J. M., Wittersheim, C., Dumont, S., Muller, C. D., Baumann, R., Poindron, P., and Duclos, B. (1996). Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J. Clin. Immunol. 16, 144-150.
42. Reinecker, H. C., Loh, E. Y., Ringler, D. J., Mehta, A., Rombeau, J. L., and MacDermott, R. P. (1995). Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology 108, 40-50.
43. Sandborn,W. J., Tremaine,W. J., Offord, K. P., Lawson, G. M., Peterson, B. T., Batts, K. P., Croghan, I. T., Dale, L. C., Schroeder, D. R., and Hurt, R. D. (1997). Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 126, 364-371.
44. Schmidt, C., Kosche, E., Baumeister, B., and Vetter, H. (1995). Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 7, 865-869.
45. Sher, M. E., Bank, S., Greenberg, R., Sardinha, T. C., Weissman, S., Bailey, S., Gilliland, R., and Wexner, S. D. (1999). The influence of cigarette smoking on cytokine levels in patients with inflammatory bowel disease. Inflam. Bowel Dis. 5, 73-78.
46. Shin, V. Y., Wang, H. Y., Liu, E. S. L., Koo, M. W. L., and Cho, C. H. (2003). Differential effects of cigarette smoke extracts on cell proliferation in gastric and colon cells. Cancer Invest. 21, 200-207.
47. Simmonds, N. J., Allen, R. E., Stevens, T. R., Van Someren, R. N., Blake, D. R., and Rampton, D. S. (1992). Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 103, 186-196.
48. Stenson, W. F., Cort, D., Rodgers, J., Burakoff, R., DeSchryver, K. K., Gramlich, T. L., and Beeken, W. (1992). Dietary supplementation with fish oil in ulcerative colitis. Ann. Intern. Med. 116, 609-614.
49. Suematsu, M., Suzuki, M., Kitahora, T., Miura, S., Suzuki, K., Hibi, T., Watanabe, M., Nagata, H., Asakura, H., and Tsuchiya, M. (1987). Increased respiratory burst of leukocytes in inflammatory bowel diseases - The analysis of free radical generation by using chemiluminescence probe. J. Clin. Lab. Immunol. 24, 125-128.
50. 4 by rat alveolar macrophages. Respiration 56, 198-203.
51. Sun, F. F., Lai, P. S., Yue, G., Yin, K., Nagele, R. G., Tong, D. M., Krzesicki, R. F., Chin, J. E., and Wong, P. Y. (2001). Pattern of cytokine and adhesion molecule mRNA in hapten induced relapsing colon inflammation in the rat. Inflammation 25, 33-45.
52. Suzuki, K., Ota, H., Sasagawa, S., Sakatani, T., and Fujikura, T. (1983). Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal. Biochem. 132, 345-352.
53. Uguccioni, M., Gionchetti, P., Robbiani, D. F., Rizzello, F., Peruzzo, S., Campieri, M., and Baggiolini, M. (1999). Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am. J. Pathol. 155, 331-336.
54. van Deventer, S. J. (1997). Review article: Chemokine production by intestinal epithelial cells: A therapeutic target in inflammatory bowel disease? Aliment. Pharmacol. Ther. 11(Suppl. 3), 116-120.
55. Wu, W. K. K., and Cho, C. H. (2004). The pharmacological actions of nicotine on the gastrointestinal tract. J. Pharmacol. Sci. 94, 348-358.
56. Ye, Y. N., Liu, E. S. L., Shin, V. Y., Wu, W. K. K., Luo, J. C., and Cho, C. H. (2004). Nicotine promoted colon cancer growth via epidermal growth factor receptor, c-Src, and 5-lipoxygenase-mediated signal pathway. J. Pharmacol. Exp. Ther. 308, 66-72.
57. Zhou, H., and Mineshita, S. (1999). The effect of Oren-gedoku-to on experimental colitis in rats. J. Pharm. Pharmacol. 51, 1065-1074.